Skip to main content
RIGL logo

RIGL · Rigel Pharmaceuticals Inc · Share Buybacks

Track RIGL — free
$42.53 -0.39 (-0.91%) At close · Nov 18 Play latest call Q3 2026 earnings call transcript
Market Cap
$800.84M
Shares
18.83M
Volume · Nov 18 304.84K Avg daily vol (3M) 252.93K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2020-08-04 $100,000,000 — —

Cash spent on buybacks by quarter

Cash deployed each quarter, with the average price paid where the company reported it (on today's share basis). Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Quarter Ended Cash Spent
2026-09-30 $1,024,000 Δ
2026-06-30 $511,000 Δ
2026-03-31 $3,740,000
2025-09-30 $0 Δ
2025-06-30 $0 Δ
2025-03-31 $0

Share counts and average prices are restated onto today's share basis across later stock splits; cash spent is as reported. ‡ marks a row kept as filed because a later split could not be attributed to this stock's shares.

Key facts CIK 1034842 CUSIP 766559702 13F (30d) 182 filings 156 filers Visit website Investor relations